Financhill
Buy
56

ARSUF Quote, Financials, Valuation and Earnings

Last price:
$27.00
Seasonality move :
5.1%
Day range:
$27.00 - $27.00
52-week range:
$20.03 - $27.00
Dividend yield:
0%
P/E ratio:
39.62x
P/S ratio:
1.83x
P/B ratio:
7.03x
Volume:
--
Avg. volume:
1.4K
1-year change:
34.8%
Market cap:
$2B
Revenue:
$1.1B
EPS (TTM):
$0.68

Price Performance History

Performance vs. Valuation Benchmarks

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Competitors

Company Revenue Forecast Earnings Forecast Revenue Growth Forecast Earnings Growth Forecast Analyst Price Target Median
ARSUF
Fagron NV
-- -- -- -- --
CLYYF
Celyad Oncology SA
-- -- -- -- --
GLPG
Galapagos NV
$84M -$0.08 5.99% 226.8% $27.34
IOBCF
Ion Beam Applications SA
-- -- -- -- --
UCBJY
UCB SA
-- -- -- -- --
Company Price Analyst Target Market Cap P/E Ratio Dividend per Share Dividend Yield Price / LTM Sales
ARSUF
Fagron NV
$27.00 -- $2B 39.62x $0.39 0% 1.83x
CLYYF
Celyad Oncology SA
$0.15 -- $6.7M -- $0.00 0% 30.84x
GLPG
Galapagos NV
$33.77 $27.34 $2.2B 21.30x $0.00 0% 7.03x
IOBCF
Ion Beam Applications SA
$18.21 -- $532.8M 24.33x $0.28 1.52% 0.82x
UCBJY
UCB SA
$163.16 -- $62B 37.32x $0.79 0.49% 8.52x
Company Total Debt / Total Capital Beta Debt to Equity Quick Ratio
ARSUF
Fagron NV
40.95% 0.767 -- 0.88x
CLYYF
Celyad Oncology SA
-- -1.240 -- --
GLPG
Galapagos NV
0.31% 0.230 0.39% 8.44x
IOBCF
Ion Beam Applications SA
26.43% 1.118 -- 0.57x
UCBJY
UCB SA
21.7% 1.093 -- 1.00x
Company Gross Profit Operating Income Return on Invested Capital Return on Common Equity EBIT Margin Free Cash Flow
ARSUF
Fagron NV
-- -- 10.32% 17.38% -- --
CLYYF
Celyad Oncology SA
-- -- -- -- -- --
GLPG
Galapagos NV
$70.5M -$56.2M -16.42% -16.48% -67.61% -$63.6M
IOBCF
Ion Beam Applications SA
-- -- 6.78% 8.22% -- --
UCBJY
UCB SA
-- -- 10.75% 13.88% -- --

Fagron NV vs. Competitors

  • Which has Higher Returns ARSUF or CLYYF?

    Celyad Oncology SA has a net margin of -- compared to Fagron NV's net margin of --. Fagron NV's return on equity of 17.38% beat Celyad Oncology SA's return on equity of --.

    Company Gross Margin Earnings Per Share Invested Capital
    ARSUF
    Fagron NV
    -- -- $1B
    CLYYF
    Celyad Oncology SA
    -- -- --
  • What do Analysts Say About ARSUF or CLYYF?

    Fagron NV has a consensus price target of --, signalling downside risk potential of --. On the other hand Celyad Oncology SA has an analysts' consensus of -- which suggests that it could fall by --. Given that Fagron NV has higher upside potential than Celyad Oncology SA, analysts believe Fagron NV is more attractive than Celyad Oncology SA.

    Company Buy Ratings Hold Ratings Sell Ratings
    ARSUF
    Fagron NV
    0 0 0
    CLYYF
    Celyad Oncology SA
    0 0 0
  • Is ARSUF or CLYYF More Risky?

    Fagron NV has a beta of -0.031, which suggesting that the stock is 103.124% less volatile than S&P 500. In comparison Celyad Oncology SA has a beta of 0.181, suggesting its less volatile than the S&P 500 by 81.876%.

  • Which is a Better Dividend Stock ARSUF or CLYYF?

    Fagron NV has a quarterly dividend of $0.39 per share corresponding to a yield of 0%. Celyad Oncology SA offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Fagron NV pays 22.48% of its earnings as a dividend. Celyad Oncology SA pays out -- of its earnings as a dividend. Fagron NV's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

  • Which has Better Financial Ratios ARSUF or CLYYF?

    Fagron NV quarterly revenues are --, which are smaller than Celyad Oncology SA quarterly revenues of --. Fagron NV's net income of -- is lower than Celyad Oncology SA's net income of --. Notably, Fagron NV's price-to-earnings ratio is 39.62x while Celyad Oncology SA's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Fagron NV is 1.83x versus 30.84x for Celyad Oncology SA. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    ARSUF
    Fagron NV
    1.83x 39.62x -- --
    CLYYF
    Celyad Oncology SA
    30.84x -- -- --
  • Which has Higher Returns ARSUF or GLPG?

    Galapagos NV has a net margin of -- compared to Fagron NV's net margin of -286.67%. Fagron NV's return on equity of 17.38% beat Galapagos NV's return on equity of -16.48%.

    Company Gross Margin Earnings Per Share Invested Capital
    ARSUF
    Fagron NV
    -- -- $1B
    GLPG
    Galapagos NV
    84.76% -$3.58 $2.9B
  • What do Analysts Say About ARSUF or GLPG?

    Fagron NV has a consensus price target of --, signalling downside risk potential of --. On the other hand Galapagos NV has an analysts' consensus of $27.34 which suggests that it could fall by -18.17%. Given that Galapagos NV has higher upside potential than Fagron NV, analysts believe Galapagos NV is more attractive than Fagron NV.

    Company Buy Ratings Hold Ratings Sell Ratings
    ARSUF
    Fagron NV
    0 0 0
    GLPG
    Galapagos NV
    0 3 1
  • Is ARSUF or GLPG More Risky?

    Fagron NV has a beta of -0.031, which suggesting that the stock is 103.124% less volatile than S&P 500. In comparison Galapagos NV has a beta of 0.236, suggesting its less volatile than the S&P 500 by 76.408%.

  • Which is a Better Dividend Stock ARSUF or GLPG?

    Fagron NV has a quarterly dividend of $0.39 per share corresponding to a yield of 0%. Galapagos NV offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Fagron NV pays 22.48% of its earnings as a dividend. Galapagos NV pays out -- of its earnings as a dividend. Fagron NV's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

  • Which has Better Financial Ratios ARSUF or GLPG?

    Fagron NV quarterly revenues are --, which are smaller than Galapagos NV quarterly revenues of $83.2M. Fagron NV's net income of -- is lower than Galapagos NV's net income of -$238.4M. Notably, Fagron NV's price-to-earnings ratio is 39.62x while Galapagos NV's PE ratio is 21.30x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Fagron NV is 1.83x versus 7.03x for Galapagos NV. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    ARSUF
    Fagron NV
    1.83x 39.62x -- --
    GLPG
    Galapagos NV
    7.03x 21.30x $83.2M -$238.4M
  • Which has Higher Returns ARSUF or IOBCF?

    Ion Beam Applications SA has a net margin of -- compared to Fagron NV's net margin of --. Fagron NV's return on equity of 17.38% beat Ion Beam Applications SA's return on equity of 8.22%.

    Company Gross Margin Earnings Per Share Invested Capital
    ARSUF
    Fagron NV
    -- -- $1B
    IOBCF
    Ion Beam Applications SA
    -- -- $131.5M
  • What do Analysts Say About ARSUF or IOBCF?

    Fagron NV has a consensus price target of --, signalling downside risk potential of --. On the other hand Ion Beam Applications SA has an analysts' consensus of -- which suggests that it could fall by --. Given that Fagron NV has higher upside potential than Ion Beam Applications SA, analysts believe Fagron NV is more attractive than Ion Beam Applications SA.

    Company Buy Ratings Hold Ratings Sell Ratings
    ARSUF
    Fagron NV
    0 0 0
    IOBCF
    Ion Beam Applications SA
    0 0 0
  • Is ARSUF or IOBCF More Risky?

    Fagron NV has a beta of -0.031, which suggesting that the stock is 103.124% less volatile than S&P 500. In comparison Ion Beam Applications SA has a beta of 1.153, suggesting its more volatile than the S&P 500 by 15.339%.

  • Which is a Better Dividend Stock ARSUF or IOBCF?

    Fagron NV has a quarterly dividend of $0.39 per share corresponding to a yield of 0%. Ion Beam Applications SA offers a yield of 1.52% to investors and pays a quarterly dividend of $0.28 per share. Fagron NV pays 22.48% of its earnings as a dividend. Ion Beam Applications SA pays out 53.12% of its earnings as a dividend. Both of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.

  • Which has Better Financial Ratios ARSUF or IOBCF?

    Fagron NV quarterly revenues are --, which are smaller than Ion Beam Applications SA quarterly revenues of --. Fagron NV's net income of -- is lower than Ion Beam Applications SA's net income of --. Notably, Fagron NV's price-to-earnings ratio is 39.62x while Ion Beam Applications SA's PE ratio is 24.33x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Fagron NV is 1.83x versus 0.82x for Ion Beam Applications SA. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    ARSUF
    Fagron NV
    1.83x 39.62x -- --
    IOBCF
    Ion Beam Applications SA
    0.82x 24.33x -- --
  • Which has Higher Returns ARSUF or UCBJY?

    UCB SA has a net margin of -- compared to Fagron NV's net margin of --. Fagron NV's return on equity of 17.38% beat UCB SA's return on equity of 13.88%.

    Company Gross Margin Earnings Per Share Invested Capital
    ARSUF
    Fagron NV
    -- -- $1B
    UCBJY
    UCB SA
    -- -- $14.5B
  • What do Analysts Say About ARSUF or UCBJY?

    Fagron NV has a consensus price target of --, signalling downside risk potential of --. On the other hand UCB SA has an analysts' consensus of -- which suggests that it could fall by --. Given that Fagron NV has higher upside potential than UCB SA, analysts believe Fagron NV is more attractive than UCB SA.

    Company Buy Ratings Hold Ratings Sell Ratings
    ARSUF
    Fagron NV
    0 0 0
    UCBJY
    UCB SA
    0 0 0
  • Is ARSUF or UCBJY More Risky?

    Fagron NV has a beta of -0.031, which suggesting that the stock is 103.124% less volatile than S&P 500. In comparison UCB SA has a beta of 0.678, suggesting its less volatile than the S&P 500 by 32.194%.

  • Which is a Better Dividend Stock ARSUF or UCBJY?

    Fagron NV has a quarterly dividend of $0.39 per share corresponding to a yield of 0%. UCB SA offers a yield of 0.49% to investors and pays a quarterly dividend of $0.79 per share. Fagron NV pays 22.48% of its earnings as a dividend. UCB SA pays out 15.96% of its earnings as a dividend. Both of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.

  • Which has Better Financial Ratios ARSUF or UCBJY?

    Fagron NV quarterly revenues are --, which are smaller than UCB SA quarterly revenues of --. Fagron NV's net income of -- is lower than UCB SA's net income of --. Notably, Fagron NV's price-to-earnings ratio is 39.62x while UCB SA's PE ratio is 37.32x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Fagron NV is 1.83x versus 8.52x for UCB SA. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    ARSUF
    Fagron NV
    1.83x 39.62x -- --
    UCBJY
    UCB SA
    8.52x 37.32x -- --

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Celestica The Best AI Stock to Buy Now?
Is Celestica The Best AI Stock to Buy Now?

Technology and hardware business Celestica (NYSE:CLS) has seen massive upward…

Will AI Disrupt SaaS Software Stocks?
Will AI Disrupt SaaS Software Stocks?

Since January 28th, software stocks in the United States have…

Why Is Meta Stock Going Higher?
Why Is Meta Stock Going Higher?

Over the last five days, shares of Instagram and Facebook…

Stock Ideas

Buy
55
Is NVDA Stock a Buy?

Market Cap: $4.6T
P/E Ratio: 65x

Sell
50
Is AAPL Stock a Buy?

Market Cap: $3.9T
P/E Ratio: 35x

Sell
40
Is GOOGL Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 29x

Alerts

Buy
77
RNG alert for Feb 21

RingCentral, Inc. [RNG] is up 34.37% over the past day.

Sell
9
FROG alert for Feb 21

JFrog Ltd. [FROG] is down 24.98% over the past day.

Buy
72
SNSE alert for Feb 21

Sensei Biotherapeutics, Inc. [SNSE] is up 23.81% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock